247 related articles for article (PubMed ID: 18328982)
1. Sclerosing bone disorders.
de Vernejoul MC
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):71-83. PubMed ID: 18328982
[TBL] [Abstract][Full Text] [Related]
2. Heritable sclerosing bone disorders: presentation and new molecular mechanisms.
de Vernejoul MC; Kornak U
Ann N Y Acad Sci; 2010 Mar; 1192():269-77. PubMed ID: 20392246
[TBL] [Abstract][Full Text] [Related]
3. Human osteopetrosis and other sclerosing disorders: recent genetic developments.
de Vernejoul MC; Bénichou O
Calcif Tissue Int; 2001 Jul; 69(1):1-6. PubMed ID: 11685426
[TBL] [Abstract][Full Text] [Related]
4. [Genetic basis for skeletal disease. Molecular advances in sclerosing bone disorders].
Michigami T
Clin Calcium; 2010 Aug; 20(8):1196-202. PubMed ID: 20675930
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in the molecular genetics of sclerosing bone dysplasias.
Van Hul W
Pediatr Pathol Mol Med; 2003; 22(1):11-22. PubMed ID: 12687886
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Schönberg disease (Chloride Channel 7 Deficiency Osteopetrosis) among the sclerosing bone disorders.
Whyte MP; Kempa LG; McAlister WH; Zhang F; Mumm S; Wenkert D
J Bone Miner Res; 2010 Nov; 25(11):2515-26. PubMed ID: 20499337
[TBL] [Abstract][Full Text] [Related]
7. A clinical and molecular overview of the human osteopetroses.
Balemans W; Van Wesenbeeck L; Van Hul W
Calcif Tissue Int; 2005 Nov; 77(5):263-74. PubMed ID: 16307387
[TBL] [Abstract][Full Text] [Related]
8. Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis.
Ihde LL; Forrester DM; Gottsegen CJ; Masih S; Patel DB; Vachon LA; White EA; Matcuk GR
Radiographics; 2011; 31(7):1865-82. PubMed ID: 22084176
[TBL] [Abstract][Full Text] [Related]
9. A Review of the Clinical, Radiological and Biochemical Characteristics and Genetic Causes of High Bone Mass Disorders.
Chen X; Yu H; Yu X
Curr Drug Targets; 2018; 19(6):621-635. PubMed ID: 29359663
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma arising in a femur with melorheostosis and osteopathia striata.
Brennan DD; Bruzzi JF; Thakore H; O'Keane JC; Eustace S
Skeletal Radiol; 2002 Aug; 31(8):471-4. PubMed ID: 12172596
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease.
Janssens K; Gershoni-Baruch R; Guañabens N; Migone N; Ralston S; Bonduelle M; Lissens W; Van Maldergem L; Vanhoenacker F; Verbruggen L; Van Hul W
Nat Genet; 2000 Nov; 26(3):273-5. PubMed ID: 11062463
[TBL] [Abstract][Full Text] [Related]
12. Osteopetrosis.
Kocher MS; Kasser JR
Am J Orthop (Belle Mead NJ); 2003 May; 32(5):222-8. PubMed ID: 12772872
[TBL] [Abstract][Full Text] [Related]
13. Camurati-Engelmann disease--a rare cause of bone pain.
Mundra V; Taxel P
Conn Med; 2012 Jan; 76(1):33-7. PubMed ID: 22372177
[TBL] [Abstract][Full Text] [Related]
14. Identification of the disease-causing gene in sclerosteosis--discovery of a novel bone anabolic target?
Balemans W; Van Hul W
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):139-42. PubMed ID: 15615113
[TBL] [Abstract][Full Text] [Related]
15. Dysosteosclerosis presents as an "osteoclast-poor" form of osteopetrosis: comprehensive investigation of a 3-year-old girl and literature review.
Whyte MP; Wenkert D; McAlister WH; Novack DV; Nenninger AR; Zhang X; Huskey M; Mumm S
J Bone Miner Res; 2010 Nov; 25(11):2527-39. PubMed ID: 20499338
[TBL] [Abstract][Full Text] [Related]
16. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW
Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
[TBL] [Abstract][Full Text] [Related]
17. Mixed-sclerosing-bone-dystrophy: 42-year follow-up of a case reported as osteopetrosis.
Pacifici R; Murphy WA; Teitelbaum SL; Whyte MP
Calcif Tissue Int; 1986 Mar; 38(3):175-85. PubMed ID: 3085895
[TBL] [Abstract][Full Text] [Related]
18. Towards a better understanding and new therapeutics of osteopetrosis.
Askmyr MK; Fasth A; Richter J
Br J Haematol; 2008 Mar; 140(6):597-609. PubMed ID: 18241253
[TBL] [Abstract][Full Text] [Related]
19. Autosomal dominant osteosclerosis.
Gelman MI
Radiology; 1977 Nov; 125(2):289-96. PubMed ID: 198844
[TBL] [Abstract][Full Text] [Related]
20. Autosomal dominant osteopetrosis revisited: lessons from recent studies.
Bollerslev J; Henriksen K; Nielsen MF; Brixen K; Van Hul W
Eur J Endocrinol; 2013 Aug; 169(2):R39-57. PubMed ID: 23744590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
